Initial combining lamivudine and adefovir dipivoxil and lamivudine/entecavir monotherapy in hepatitis B e antigen-positive chronic hepatitis B with high viral load
机构：[1]The First Affiliated Hospital of Kunming MedicalUniversity, Kunming, China昆明医科大学附属第一医院[2]The Third People’s Hospital of Kunming, Kunming,China[3]Faculty of Medicine, Prince of Songkla University,Hat Yai, Songkhla, Thailand[4]Haiyuan Medical College, Kunming MedicalUniversity, Kunming, China[5]The First People’s Hospital of Kunming, Kunming,Kunming, China[6]The Yunnan General Hospital of The ChinesePeople’s Armed Police Forces, Kunming, China[7]The Third People’s Hospital of Yunnan Province,Kunming, China
第一作者机构：[1]The First Affiliated Hospital of Kunming MedicalUniversity, Kunming, China
推荐引用方式(GB/T 7714)：
You J.,Liu H. E.,Chen H. Y.,et al.Initial combining lamivudine and adefovir dipivoxil and lamivudine/entecavir monotherapy in hepatitis B e antigen-positive chronic hepatitis B with high viral load[J].INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES.2014,21:322-322.doi:10.1016/j.ijid.2014.03.1085.
APA：
You, J.,Liu, H. E.,Chen, H. Y.,Feng, X.,Zhuang, L....&Rao, S. F..(2014).Initial combining lamivudine and adefovir dipivoxil and lamivudine/entecavir monotherapy in hepatitis B e antigen-positive chronic hepatitis B with high viral load.INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES,21,
MLA：
You, J.,et al."Initial combining lamivudine and adefovir dipivoxil and lamivudine/entecavir monotherapy in hepatitis B e antigen-positive chronic hepatitis B with high viral load".INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES 21.(2014):322-322
医学